Back to Search
Start Over
Istradefylline for the treatment of Parkinson's disease: is it a promising strategy?
- Source :
- Expert opinion on pharmacotherapy. 19(16)
- Publication Year :
- 2018
-
Abstract
- Introduction: Istradefylline (ISD) is a new drug developed for the treatment of Parkinson’s disease (PD). It is an adenosine receptor A2A antagonists that will represent an important option for pat...
- Subjects :
- 0301 basic medicine
Drug
Parkinson's disease
media_common.quotation_subject
Disease
Pharmacology
Antiparkinson Agents
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Double-Blind Method
medicine
Humans
Pharmacology (medical)
media_common
business.industry
Parkinson Disease
General Medicine
Istradefylline
medicine.disease
030104 developmental biology
Adenosine Receptor A2a
chemistry
Purines
business
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 17447666
- Volume :
- 19
- Issue :
- 16
- Database :
- OpenAIRE
- Journal :
- Expert opinion on pharmacotherapy
- Accession number :
- edsair.doi.dedup.....02a3fb27866d42cc23cbb9776af70ef7